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CKS proteins are evolutionarily conserved cyclin-
dependent kinase (CDK) subunits whose functions
are incompletely understood. Mammals have two
CKS proteins. CKS1 acts as a cofactor to the ubiqui-
tin ligase complex SCFSKP2 to promote degradation
of CDK inhibitors, such as p27. Little is known about
the role of the closely related CKS2. Using a Cks2/
knockoutmousemodel, we show that CKS2 counter-
acts CKS1 and stabilizes p27. Unopposed CKS1
activity in Cks2/ cells leads to loss of p27. The re-
sulting unrestricted cyclin A/CDK2 activity is accom-
panied by shortening of the cell cycle, increased
replication fork velocity, and DNA damage. In vivo,
Cks2/ cortical progenitor cells are limited in their
capacity to differentiate into mature neurons, a phe-
notype akin to animals lacking p27. We propose
that the balance betweenCKS2 andCKS1modulates
p27 degradation, and with it cyclin A/CDK2 activity,
to safeguard replicative fidelity and control neuronal
differentiation.
INTRODUCTION
The eukaryotic cell cycle comprises a series of precisely
controlled events that coordinate cell growth and differentiation.
Cell cycle progression is driven by oscillating activity of cyclin-
dependent kinases (CDKs). CDK activity is determined by peri-
odic expression of activating cyclins and counteracted by
binding to CDK inhibitory proteins (CKIs), as well as a combina-
tion of activating and inhibitory CDK phosphorylation. Feedback
regulation via ubiquitin-dependent proteasomal degradation of356 Developmental Cell 23, 356–370, August 14, 2012 ª2012 Elseviecyclins andCKIs controls CDK activity and transitioning between
different cell cycle stages.
The CDK catalytic subunit CDK2 associates with cyclins E and
A and is active from late G1 until the onset of mitosis (Pagano
et al., 1993). Gene disruption in murine models indicates that
CDK2 is not essential for survival (Berthet et al., 2003; Ortega
et al., 2003), as CDK1 can compensate for its functions (Santa-
marı´a et al., 2007). However, acute inhibition of CDK2 in prolifer-
ating cells is not tolerated and has revealed a nonredundant
and rate-limiting role for cyclin A-bound CDK2 (cyclin A/CDK2)
in regulating the G1/S transition (Merrick et al., 2011). Cyclin
A/CDK2 promotes firing of DNA replication origins and its de-
regulation leads to aberrant replication, accumulation of DNA
damage and loss of DNA damage checkpoint control (Merrick
et al., 2008; Tane and Chibazakura, 2009; Wheeler et al., 2008).
CDK2 is also an important regulator of stem cell maintenance
and differentiation. As an example, in the central nervous system,
the length of G1 and S phase are instrumental in controlling cell
cycle exit and neuronal maturation. Consistently, loss of CDK2
activity results in the depletion of neural stem cells (Caillava
et al., 2011; Jablonska et al., 2007).
CKS (cyclin dependent-kinase subunit) proteins are evolu-
tionarily conserved small proteins, which tightly associate with
CDKs. Mammalian cells contain two CKS paralogs, CKS1 and
CKS2, that share over 80% sequence identity. These bind
to CDK2 and CDK1-containing CDK complexes during cell cycle
phases when these are active (Egan and Solomon, 1998). CKS
proteins are essential for cell proliferation as Cks1 and Cks2
double knockout mice are not viable (Martinsson-Ahlze´n et al.,
2008). The essential function of CKS proteins is still under
debate. It could relate to its function in specifying multisite
phosphorylation of a crucial subset of CDK substrates (Patra
et al., 1999; Reynard et al., 2000; Ko˜ivoma¨gi et al., 2011). Alter-
natively, functions in transcription have been reported in yeast
(Morris et al., 2003; Holic et al., 2010; Yu et al., 2005) and
mammalian cells (Martinsson-Ahlze´n et al., 2008; Westbrookr Inc.Open access under CC BY license.
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facilitating checkpoint-resistant cyclin A degradation by the
APC in early mitosis (van Zon et al., 2010; Wolthuis et al.,
2008). To date, it is poorly understood why higher eukaryotes
possess two CKS proteins asmost knownCKS protein functions
are shared between the two paralogs. Using the Cks1 knockout
mousemodel, it was revealed that CKS1 facilitates S phase entry
by accelerating degradation of the CDK2 inhibitor, p27 (Spruck
et al., 2001). Accordingly, Cks1/ mice accumulate excess
p27 and are small compared to wild-type littermates. Mecha-
nistically, CKS1 acts as a cofactor for the E3 ubiquitin ligase
complex SCFSKP2 in p27 ubiquitylation. CKS1 bridges the LRR
domain in SKP2 and phosphorylated p27 and induces a confor-
mational change in SKP2 for optimal substrate positioning (Hao
et al., 2005; Sitry et al., 2002; Yao et al., 2006). Although CKS2
shares a similar CDK interaction site with CKS1, as well as the
anion-binding pocket that recognizes phosphorylated p27,
CKS2 lacks the residues in the N terminus of CKS1 that are
required for interacting with SKP2 (Hao et al., 2005). Mice lacking
Cks2 do not show any overt phenotypes except sterility in both
sexes (Spruck et al., 2003). This has been attributed to the
absence of CKS1 expression in germ cells and thus cannot
substitute for CKS2 function in these cells.
In this study, we have re-examined the role of CKS2. Although
cells lacking CKS1 have elevated p27 and reduced cyclin
A/CDK2 activity, we observe that the opposite is true in cells
lacking CKS2. p27 stability is reduced, causing replication stress
and DNA damage checkpoint failure due to increased cyclin
A/CDK2 activity. In vivo, CKS2 is required to promote neuronal
differentiation during brain development. We propose a model
in which the balance of CKS2 and CKS1 regulates p27 stability
to fine-tune CDK activity in maintaining replicative fidelity and
controlling neuronal differentiation.
RESULTS
CKS2 Differs from CKS1 in Controlling Cell-Cycle
Progression
To investigate cell cycle progression in the absence of CKS2, we
derived mouse embryonic fibroblasts (MEFs) from animals har-
boring a genomic Cks2/ deletion. We first assessed whether
the absence of CKS2 had any effect on the overall duration of
the cell cycle in spontaneously immortalized MEFs using the
3T3 protocol (Todaro and Green, 1963). Using live microscopy
on MEFs grown in culture, we measured the time taken for these
cells to divide (Figure 1A). We compared cells lacking CKS2
to wild-type controls and to cells lacking the closely related
CKS1. As expected, due to an increased level of the CDK inhib-
itor p27 (Spruck et al., 2001), Cks1/ cells showed a long delay
in cell cycle progression. Their overall cell cycle duration was
almost three times that of wild-type cells. Surprisingly, Cks2/
cells divided significantly faster, with average cell cycle duration
15% shorter than wild-type cells. MEFs may display varying cell
cycle lengths depending on their mode of immortalization. We
therefore compared spontaneously immortalized MEFs to those
independently immortalized at early passages by retrovirally
delivered shRNA against p53 (Dickins et al., 2005), which often
have shorter cell cycles. Although the measured cell cycle dura-
tions were thus consistently shorter, Cks1/ sh-p53 silencedDevelopmental Cell 23, 356–370, AMEFs still proliferated significantly slower and Cks2/ cells
divided 15% faster than wild-type controls. This revealed that
despite their similarity, CKS1 andCKS2 affect cell cycle progres-
sion in opposing manners.
To examine whether the duration of specific cell cycle stages
was affected by the absence of CKS1 and CKS2, we examined
cell cycle profiles of exponentially dividing cells by flow cyto-
metric analysis of DNA content after staining with propidium
iodide (Figure 1B). Cks1/ cells harbored largely widened G1
and S phase populations, consistent with a cell cycle delay at the
G1/S transition due to elevated p27. Cks2/ cells showed a
reduced G1 population and an increased fraction of cells in
S phase, consistent with accelerated progression through
the G1/S boundary. To substantiate this cell cycle analysis,
we pulse-labeled cells with the thymidine analog bromodeox-
yuridine (BrdU) and followed the fate of the labeled cells over
the course of 24 hr (Figure 1D). In agreement with the flow
cytometry profile, Cks1/ and Cks2/ cells both showed
a higher than wild-type proportion of cells with positive BrdU
uptake. Cks1/ cells showed twice and Cks2/ cells three
times as many BrdU-incorporating cells compared to wild-
type. Upon washout of the BrdU label, we analyzed how the
ratio of labeled versus unlabeled G1 cells developed over time
(Figure 1D). As the labeled cells progress from S phase through
G2 and mitosis into the next G1 phase, the proportion of labeled
versus unlabeled G1 cells increases. This increase occurred at
a much faster rate in Cks2/ cells, compared to wild-type,
suggestive not only of faster entry into S phase but also faster
progression through G2 and mitosis. Cks1/ cells on the other
hand, despite the initially high fraction of BrdU-incorporating
cells, displayed only a very slow increase in the fraction of
labeled over unlabeled G1 cells. This is consistent with delayed
entry and slow progression through S phase of Cks1/ cells.
Taken together, these results suggest that the increased S
phase population in Cks1/ and Cks2/ cells arises for
different reasons. Cks1/ cells progress slowly through
S phase. In contrast, Cks2/ cells show a high proportion of
S phase cells because of a fast G1/S transition and an overall
shorter cell cycle.
CKS2 Guards Replicative Fidelity
To obtain further insight into S phase progression in Cks2/
cells, we examined replication dynamics using molecular DNA
combing. This technique measures the speed of individual repli-
cation forks as well as the frequency of replication initiation
events. Asynchronously growing cells were sequentially pulse-
labeled with two thymidine analogs, iododeoxyuridine (IdU)
and chlorodeoxyuridine (CldU), for 20 min each. DNA was
combed on silanized glass slides, and stretches of newly synthe-
sized DNA were visualized by immunofluorescence staining of
IdU andCldU (Figure 2A, shown as green and red tracks, respec-
tively). Velocity of individual replication forks was calculated by
dividing the length of each fluorescent segment (1 mm z2 kb)
by the time of the pulse (20 min), as previously described (Conti
et al., 2001; Seiler et al., 2007). This analysis revealed that
Cks2/ cells showed a small but significant and reproducible
(p < 0.001, Mann-Whitney) increase in fork velocity compared
to wild-type cells. The mean fork velocity in Cks2/ cells was
1.96 kb/min versus 1.79 kb/min in wild-type cells. The oppositeugust 14, 2012 ª2012 Elsevier Inc. 357Open access under CC BY license.
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Figure 1. Accelerated Cell-Cycle Progression in Cks2–/– MEFs
(A) Time-lapse microscopy of asynchronously growing wild-type, Cks2/ and Cks1/ MEFs. MEFs were immortalized using shRNA against p53. Wild-type
MEFs were infected with a retrovirus expressing histone H2B-GFP,Cks2/ and Cks1/MEFs expressed histone H2B-mCherry. Wild-type and knockout MEFs
were mixed and imaged. The time between two successive anaphases was recorded for at least 50 cells of each genotype; the mean is shown. An example of
a wild-type and Cks2/ cell is shown. Alternatively, MEFs were immortalized using the 3T3 protocol, and cell cycle duration was measured as the duration from
one cytokinesis to the next for at least 50 cells per genotype.
(B) FACS analysis of DNA content to generate cell cycle profiles of asynchronously proliferating wild-type, Cks2/ and Cks1/ MEFs.
(C) Quantification of the cell cycle populations by FACS.
(D) Experimental design and example of the FACS pattern of wild-type MEFs at time 0, depicting the G1, BrdU-positive and G2 gates. The ratio of BrdU-positive
cells with a G1 DNA content (labeled ‘‘early S’’) over unlabeled G1 cells was followed over a 24 hr chase.
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reduced to a mean of 1.4 kb/min. The slow fork progression
could in part explain the slower progression through S phase
of Cks1/ cells.
Changes in fork velocity may impact on replicative fidelity (An-
glana et al., 2003; Courbet et al., 2008). We therefore analyzed
whether the observed changes in replication fork speed in
Cks2/ and Cks1/ cells were associated with DNA damage
(Figure 2B). Western blotting indicated the presence of DNA
damage in asynchronously growing Cks2/ cells, as seen
by increased levels of phosphorylated histone H2AX (gH2AX).
This was further confirmed by counting the number of nuclei
harboring positive gH2AX foci in asynchronously growing
MEFs (Figure 2B, right). Cks2/ MEFs had almost 6-fold more
cells with gH2AX-positive nuclei. The presence of gH2AX is
suggestive of double-strand DNA breaks, a common conse-
quence of stalled or collapsed replication forks during S phase.
The increased fork velocity could be a reason for replication
fork damage. In Cks1/ cells, where fork velocity was de-
creased and the overall cell cycle duration prolonged, no indica-
tion of DNA damage was observed. Our western blot analysis
also provided further insight into the altered cell cycle profiles
of Cks2/ cells. Asynchronously growing Cks2/ cells had
lower cyclin B levels, consistent with fast progression through
the G2 andmitosis (compare Figure 1C).Cks1/ cells displayed
normal cyclin B but elevated cyclin E levels, as previously re-
ported (Spruck et al., 2001). This has been postulated to com-
pensate for increased p27 in these cells. Cyclin A levels were
comparable across all three genotypes.
One possible explanation for increased gH2AX levels in
Cks2/ cells could be stalled or broken DNA replication forks.
To address whether there was evidence of replication fork
stalling, we analyzed 500 replicons in wild-type, Cks1/ and
Cks2/ DNA fibers by molecular combing and scored the frac-
tion of bidirectional forks with asymmetries in fork progression
during the second pulse (Figure 2C). Asymmetries between the
left and right arms arise if one fork continues to replicate,
whereas the other fork slows down or stalls. Cks2/ cells dis-
played almost twice the number of such asymmetries when
compared to wild-type cells. Cks1/ cells did not demonstrate
statistically significant changes in the number of asymmetrical
replicons compared to wild-type, consistent with the lack of
gH2AX induction in these cells. These findings are consistent
with the possibility that DNA damage in Cks2/ cells arises
because of stalled or broken replication forks.
In response to stalled replication forks, it is thought that
dormant replication origins in the vicinity are activated to aid
fork recovery in order to prevent persistence of replication inter-
mediates or unreplicated regions into mitosis (Ge and Blow,
2010; Kawabata et al., 2011). Examination of active origin dis-
tribution in Cks2/ cells revealed that the mean interorigin
distance was increased to 223 kb, compared to 175 kb in wild-
type cells (Figure 2D). This increase is expected from the
observed elevated fork velocity, as fork velocity and interorigin
distances show a linear correlation (Conti et al., 2007; Seiler
et al., 2007). Despite the mean increase in interorigin distance,
we observed a population of shorter interorigin distances, below
100 kb, in Cks2/ cells, which was not present in the wild-type
control. The appearance of this subset of short interoriginDevelopmental Cell 23, 356–370, Adistances is in keeping with the firing of dormant origins in the
vicinity of stalled replication forks.
CKS2 Is Required for Cell-Cycle Arrest in Response to
DNA Damage
Replication fork stalling and associated double-strand DNA
breaks typically trigger a DNA damage response (DDR) with
temporary delay to cell cycle progression (reviewed in Bensimon
et al., 2011). Considering our evidence for fork stalling and DNA
breaks, it was surprising that cell cycle progression appeared
accelerated rather than delayed in Cks2/ cells. This raised
the question whether DDR was functional. To address this, we
investigated the response of Cks2/ cells to exogenous DNA
damage.
Asynchronously growingwild-type orCks2/MEFswere irra-
diated with a moderate dose (5 Gy) of g-irradiation from a 137Cs
source. Five hours later, a strong gH2AX signal could be de-
tected by western blotting in wild-type cells (Figure 3A). Like-
wise, in Cks2/ cells, despite the endogenous presence of
gH2AX in unirradiated cells, gH2AX was further augmented after
irradiation.We conclude that early events of DNAdamage detec-
tion that result in activation of ATM/ATR kinase and H2AX phos-
phorylation were largely functional in both wild-type andCks2/
cells (Figure 3A).
The next molecular event in the DDR pathway we analyzed
was activation of the downstream effector checkpoint kinase
CHK1. In contrast to wild-type MEFs, Cks2/ cells showed a
detectable level of spontaneous CHK1 activation in the absence
of exogenous DNA damage (detected using a phosphospecific
S317 CHK1 antibody) (Figure 3A) (Wilsker et al., 2008). This is
consistent with the presence of endogenous DNA damage as
a consequence of replication abnormalities. Upon irradiation,
phospho-CHK1 accumulated both in wild-type and Cks2/
cells, suggesting that much of the DDR up to activation of
effector checkpoint kinases is operational in the absence of
CKS2. Similar findings were obtained when we assessed phos-
phorylation of CHK2 after irradiation (Figure 3A).
In response to CHK1 and CHK2 activation, wild-type cells
accumulate in G2 phase of the cell cycle because of inhibition
of G2/M transition. However, despite intact DDR signaling, there
was no accumulation of Cks2/ cells in the G2 phase of the cell
cycle in response to irradiation (Figure 3B). This checkpoint
defect was reversed when Cks2/ cells were reconstituted
with a vector expression wild-type Cks2 (Figure 3B, lower
panels). Therefore, cell cycle control network at the G2/M transi-
tion appears to be unresponsive to CHK1 and CHK2 signaling in
Cks2/ cells. This could explain how Cks2/ cells accumulate
DNA damage but nevertheless progress through an accelerated
cell cycle.
Mutations in genes involved in DDR frequently lead to cell
sensitivity to DNA damaging agents (Polo and Jackson, 2011).
We tested the sensitivity of Cks2/ cells to an agent that
induces replicative stress by inhibiting replicative DNA polymer-
ases, aphidicolin. In line with our observations of defective cell
cycle arrest in response to replication-induced DNA damage,
Cks2/ cells displayed increased sensitivity to low doses of
aphidicolin (Figure 3C). This confirms the requirement of CKS2
for an intact response to replication-induced DNA damage. A
recent screen for DDR genes, carried out in a human cell line359ugust 14, 2012 ª2012 Elsevier Inc.Open access under CC BY license.
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Figure 2. Cks2–/– MEFs Harbor Replicative Abnormalities and DNA Damage
(A) Molecular combing of DNA fibers from MEFs, sequentially labeled with IdU and CldU for 20 min each. Replication fork velocity was calculated by dividing
the total length of two sequential IdU and CldU signals by pulse time. A typical DNA fiber track (IdU, green; CldU, red) is depicted together with a histogram of
the fork velocity distribution (red line indicates mean fork velocity of wild-type). The distributions in bothCks2/ and Cks1/MEFs were different fromwild-type
(p < 0.001, Mann-Whitney).
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2011), found that silencing of Cks2 using siRNA targeting re-
sulted in a ‘‘medium’’ suppression of the DDR pathway, consis-
tent with our results.
Increased Cyclin A/CDK2 Activity in Cks2–/– Cells
Cell cycle arrest in G2 in response to DNA damage requires
inhibition of CDK2-associated kinase activity. The inability of
Cks2/cells to impose a G2 arrest, despite intact CHK1 and
CHK2 signaling pathways, suggests that CDK2 inhibition was
compromised. To investigate this, we initially measured cyclin
A-associated CDK2 activity in asynchronously proliferating
MEFs. We immunoprecipitated cyclin A from wild-type, Cks2/
and Cks1/ cells and performed an in vitro kinase activity
assay using histone H1 as a substrate (Figure 4A). Comparable
amounts of CDK2 were precipitated in each case. As reported,
probably because of increased p27 levels, cyclin A/CDK2 ac-
tivity was reduced in Cks1/ cells (Spruck et al., 2001). In con-
trast, Cks2/ cells displayed markedly elevated cyclin A/CDK2
activity. Interestingly, cyclin E/CDK2 activity was not affected in
Cks2/ cells (Figure S1B, available online).
To confirm that elevated cyclin A/CDK2 activity was a direct
consequence of Cks2 deletion, we reconstituted the Cks2/
cell line with a retroviral construct expressing Cks2 (Figures 4B
and 4D). This corrected cyclin A/CDK2 activity in Cks2/ cells
downward to wild-type levels. Restoration of Cks2 also pre-
vented the accumulation of gH2AX in these cells. Apart from
binding the CDKs, CKS proteins harbor a conserved anion-
binding domain that binds phosphosubstrates. We next exam-
ined whether the effect of CKS2 on cyclin A/CDK2 activity is
dependent on the ability of CKS2 to bind phosphosubstrates.
Triple mutations in the anion-binding pocket of CKS proteins
(K11E, S51E, and R71A) are known to abrogate the ability of
CKS proteins to bind phosphoproteins based on structural
studies (Bourne et al., 1996). The triple mutant (hereby denoted
as Cks2Mut) was unable to correct gH2AX levels (Figure 4C) or
cyclin A/CDK2 hyperactivity in Cks2/ cells (Figure 4D), sug-
gesting that CKS2 binds a phosphorylated substrate to control
cyclin A/CDK2 activity.
We next examined whether the replication and DNA damage
phenotypes observed in Cks2/ cells could be explained by
increased cyclin A/CDK activity.We employed siRNA against cy-
clin A to reduce its protein levels (Figure 4E). Reduced cyclin A
levels in Cks2/ cells entirely reverted increased gH2AX back
to wild-type levels. This suggests that DNA damage in Cks2/
cells was caused by unrestrained cyclin A/CDK2 activity. If it is
correct that DNA damage in Cks2/ cells stemmed from accel-
erated DNA replication fork progression, we would expect the
enhanced fork velocity to be corrected by cyclin A knockdown.
We therefore measured replication fork velocity in Cks2/ cells,
treated with control or cyclin A siRNA (Figure 4F). Control siRNA-
treated cells showed accelerated forks, moving with a mean(B) Left: Western blotting of extracts from wild-type (WT), Cks1/ and Cks2/M
gH2AX foci in nuclei of asynchronously dividing MEFs. Representative image upo
positive for gH2AX staining, 1,000 nuclei were counted per genotype.
(C) Quantification of fork asymmetry between left and right forks. Mean and stand
forks were analyzed for each genotype.
(D) Histogram of interorigin distances in wild-type and Cks2/ MEFs.
Developmental Cell 23, 356–370, Avelocity of 1.98 kb/min, consistent with our previous measure-
ments. Cyclin A downregulation in these cells caused a reduction
of mean fork speed to 1.57 kb/min, somewhat below what we
observed in wild-type cells. Similarly, when we applied the
CDK inhibitor roscovitine to Cks2/ cells, we observed a
reduction in gH2AX levels as well as replication fork velocity
(Figure S1A).
Together, these observations suggest that replication fork
progression is sensitive to the levels of cyclin A/CDK2 activity
and that replication abnormalities and DNA damage observed in
Cks2/ cells were consequences of increased cyclin A/CDK2
activity. Moreover, this is dependent on the intactness of the
phosphobinding pocket of CKS2.
CKS2 Is Required to Maintain p27 Levels
CKS1 acts as an activating cofactor of SKP2 to facilitate ubiqui-
tylation and subsequent proteasome-mediated degradation of
p27 by recruiting SKP2 through a unique N-terminal extension
that is not shared with CKS2 (Hao et al., 2005). CKS2 is therefore
unable to interact with SKP2 and cannot substitute for CKS1 in
promoting p27 degradation (Hao et al., 2005; Sitry et al., 2002;
Spruck et al., 2001). In contrast, the anion-binding pocket
through which CKS proteins interact with phosphorylated p27
is conserved in CKS2. Given that the ability of CKS2 to control
cyclin A/CDK2 activity is dependent on its phosphoprotein bind-
ing domain (Figures 4C and 4D), we envisioned the possibility
that CKS2 competes with CKS1 for binding to phosphorylated
p27 and thereby could act as a buffer that protects p27 from
degradation.
To address whether this was the case, we compared p27
levels in wild-type, Cks2/ cells and Cks1/ cells (Figure 5A).
As expected, we detected elevated p27 levels in Cks1/ cells.
Consistent with the possibility that CKS2 protects p27 from
degradation, p27 levels were lower in extracts derived from
Cks2/ cells. Using a CKS affinity column, we pulled down
CDK complexes from these extracts. This experiment showed
that about twice more p27 was associated with CDK complexes
in Cks1/ cells (Figure 5Ai). Compared to wild-type cells only
a third of CDK was bound to p27 in Cks2/ cells. This finding
was confirmed using an alternative method. We immunoprecip-
itated p27 from the cell extracts and specifically probed for
CDK2 bound to it (Figure 5Aii). Again p27 was less abundant in
Cks2/ extracts. Despite efficient pull down of p27 by immuno-
precipitation, less p27 was bound to CDK2 in Cks2/ cells
compared to wild-type or Cks1/ cells. To further confirm the
direct relationship between p27 levels and CKS2, we employed
siRNA to acutely knockdownCks2 in wild-type cells (Figure 5Aiii).
p27 levels decreased after transient silencing of Cks2 in wild-
type cells, affirming our finding in Cks2/ MEFs. Lower levels
of p27 bound to CDK2 in Cks2/ cells could explain the higher
level of cyclin A/CDK2 activity that we observed. If our hypoth-
esis was correct that CKS2 protects p27 from degradation, itsEFs using the indicated antibodies. Right: Immunofluoresence demonstrating
n which threshold was set was shown. To determine the percentage of nuclei
ard deviation of three independent experiments is shown in which a total of 500
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Figure 3. Defective DNA Damage Response in the Absence of Cks2
(A) Proteins extracted from wild-type (WT) and Cks2/ MEFs before and after irradiation were subjected to western blotting using the indicated antibodies.
(B) Failure of cell cycle arrest despite checkpoint kinase activation. Top: Wild-type and Cks2/ MEFs were exposed to 5 Gy of g-irradiation. After 5 hr, the cell
cycle distribution was analyzed by FACS analysis of DNA content. Bottom: Reconstitution of Cks2/ MEFs with wild-type Cks2 or empty vector (EV).
(C) Sensitivity of Cks2/ MEFs to replication stress. Wild-type and Cks2/ cells were plated at equivalent densities and exposed to increasing doses of
aphidicolin. Each data point represents the mean and standard error of three experimental replicates (* indicates p < 0.01).
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CKS2 in Replication and Neurodevelopmentrate of destruction should be accelerated in Cks2/ cells. We
tested this by assaying p27 decay after cycloheximide treatment
to inhibit protein synthesis (Figure 5B). To control for differences
in cell cycle profiles, MEFs were synchronized by release from
nocodazole. Compared to wild-type cells, p27 had a greatly362 Developmental Cell 23, 356–370, August 14, 2012 ª2012 Elsevierreduced half-life in the Cks2/ background (over 50% of p27
was degraded in Cks2/ cells within 15 min, whereas in the
wild-type, p27 remained largely stable).
To show that CKS2 competes with CKS1 for binding to phos-
phorylated p27, we carried out an in vitro binding assaymodifiedInc.Open access under CC BY license.
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CKS2 in Replication and Neurodevelopmentfrom Hao et al. (2005) (Sitry et al., 2002). Recombinant CKS1
fused to the FLAG epitope binds the phosphorylated p27
peptides in the presence of the SKP1/SKP2 complex (Figure 5C).
Recombinant CKS2when added at a 1:1 ratio to CKS1 efficiently
reduced binding of CKS1 to phosphorylated p27. The triple
CKS2mutant (Cks2-Mut), which was incapable of binding phos-
phorylated p27, did not compete with CKS1 for binding. If our
model was correct that CKS2 competes with CKS1 for p27
binding and protects it from degradation, we would expect
Cks2/ cells to have increased ubiquitylation of p27. We exam-
ined cellular ubiquitylation of p27 by immunoprecipitation of p27
in MEFs in the presence of the proteasome inhibitor MG132
and looked for the level of ubiquitylation (Figure 5D). In Cks1/
cells, p27 ubiquitylation was markedly reduced, in agreement
with published literature (Spruck et al., 2001). On the other
hand, Cks2/ cells showed increased ubiquitylation, consistent
with the observed decreased stability (Figure 5B). We predict the
loss of p27 in Cks2/ cells to be due to unopposed action of
CKS1. Applying siRNA to Cks1, we found reduced ubiquitylation
of p27 in cells lacking Cks2 (Figure 5D). To further demonstrate
that reducing CKS1 levels in cells lacking CKS2 had functional
significance, we tested whether restoration of p27 levels could
reverse the increased cyclin A/CDK2 activity. By using siRNA
against Cks1 in Cks2/ cells (Figure 5E), we found that de-
creasing Cks1 expression in the Cks2/ background restored
p27 levels and reduced cyclin A/CDK2 activity. Similarly, tran-
sient overexpression of p27 in Cks2/ cells also reduced cyclin
A/CDK2 activity (Figure S2). These observations support the
possibility that decreased p27 in Cks2/ cells is due to unre-
strained CKS1 activity and that CKS2 and CKS1 together work
to balance cellular p27 levels.
CKS Proteins Control Neuronal Differentiation
Both SKP2 and p27 have been implicated in the regulation of cell
differentiation and organogenesis during mammalian develop-
ment. In particular, overexpression or depletion of either protein
has been linked to abnormalities in neurogenesis (Nguyen et al.,
2006b). Given our results in cultured cells, which implicate CKS2
in balancing p27, we wondered whether CKS2 might play a role
in neurogenesis during mouse development. In the embryonic
neocortex, progenitor cells divide in the ventricular (VZ) and sub-
ventricular zones (SVZ; Figure 6A). As neurons mature, they
migrate outward from the VZ and SVZ to the intermediate zone
(IZ) and finally form laminar layers in the cortical plate (CP). As
progenitors mature, they sequentially express a series of tran-
scription factors, which display a zonal pattern of expression
from the VZ to the CP (Pax6/ Tbr2/ Tbr1, Figure 6A).
We examined fetal brains from day E13.5 embryos in the
Cks2/ and Cks1/ backgrounds and compared them with
wild-type littermates (Figure 6B). Cks2/ brains maintained
a comparable Pax6-positive population of apical progenitors
compared towild-type littermates. However, therewas amarked
loss of Tbr2-positive cells, consistent with a reduction in the
basal progenitor population. Consequently, there was also
a reduction of Tbr1-positive mature neurons in upper cortical
layers. This distribution is suggestive of a defect in neuronal
differentiation, reminiscent of the defect seen in p27 knockout
brains (Nguyen et al., 2006a, 2006b). Consistent with our findings
in MEFs, we found that cell cycle duration was shortened inDevelopmental Cell 23, 356–370, Acortical progenitors in the Cks2/ brain (highlighted by an
increased proportion of cells staining positive for the mitotic
marker phosphohistone H3 after animals were pulsed-labeled
with BrdU for 24 hr; Figure S3C).
We observed a different outcome in Cks1/ mice. There
was an overall increase in the Pax6 population in all zones. The
Tbr2-positive population was increased in the VZ, whereas
the subsequent Tbr1-positive population remained unaltered.
The increase in Tbr2-positive cells may represent premature
neuronal differentiation in the VZ secondary to elevated p27.
We examined p27 expression and found that this was indeed
increased in the Cks1/ cortex, particularly in the VZ (Fig-
ure S3B). The increase in p27 levels was sustained up to the IZ
but not at the CP. High p27 staining at the VZwas an unexpected
finding, as p27 is not normally expressed at the VZ, where cells
are actively dividing. We suspect, therefore, that the high level
of Pax6-positive cells in the Cks1/ cortex may represent an
increased population of nondividing progenitor cells.
To demonstrate that the defect in neurodevelopment was
directly related to deletion of CKS proteins in the developing
brain, we checked that both CKS2 and CKS1 were expressed
in the developing cortex (Figure S3A). CKS1 expression was
particularly enriched at the VZ in the E13.5 cortex (CKS2 expres-
sion at this layer is absent). CKS2, however, was expressed in
the SVZ and increased in the IZ, where CKS1 expression
decreases. In the CP, both proteins were expressed (though
CKS2 levels are lower than CKS1).
Taken together, these results lead us to propose a model
where in the normal developing brain, high CKS1 expression
in the VZ encourages rapid degradation of p27, thus encour-
aging progenitor cell proliferation. As neurogenesis progresses
through the cortical layers into the IZ, CKS2 expression in-
creases and CKS1 expression decreases, promoting p27 accu-
mulation and neuronal differentiation and migration toward the
cortical surface. In the CP, where mature neurons reside, both
CKS proteins are expressed. We also observed this pattern of
expression in certain areas of the adult brain (unpublished
data). The functional significance of this is yet unknown and
further studies are currently warranted.
DISCUSSION
CKS2 Antagonizes CKS1 in Controlling p27 Levels
Through our study of cells derived from mice lacking CKS2, we
identified a role for CKS2 opposed to its close paralog CKS1.
We propose a model in which CKS2 competes with CKS1 for
binding to phosphorylated p27 (Figure 7). In this model, CKS2,
which lacks the SKP2 binding domain, protects p27 frombinding
to CKS1 and consequent degradation. The balance of CKS1
versus CKS2 will determine p27 stability and fine-tune its cellular
levels.
In the absence of CKS2, p27 stability is reduced, leading
to lower cellular p27 levels. The consequences are manifold
but mostly attributable to increased activity of cyclin A/CDK2.
Cks2/ cells showed an overall shortened cell cycle, consistent
with reduced levels of a cell cycle inhibitor. S-phase in particular,
was affected with an increased average replication fork velocity,
accompanied by accumulation of DNA damage. The regulation
of replication fork speed by cyclin A/CDK2 activity has not363ugust 14, 2012 ª2012 Elsevier Inc.Open access under CC BY license.
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Figure 4. Increased Cyclin A/CDK2 Activity in Cks2–/– MEFs
(A) Cyclin Awas immunoprecipitated from cell extracts obtained fromwild-type,Cks2/ andCks1/MEFs. In vitro kinase activity using recombinant histone H1
as a substrate was measured. The kinase activity was normalized to the levels of CDK2 recovered in each sample.
(B) Wild-type CKS2 reverses increased cyclin A/CDK2 activity and DNA damage in Cks2/ MEFs. Protein levels and cyclin A-associated kinase activity were
measured in wild-type or Cks2/ MEFs, infected with either an empty retroviral vector (EV) or a vector containing Cks2.
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tion, we saw an increased incidence of asymmetric forks. This is
indicative of fork stalling, which is a likely cause for DNAdamage.
Regardless, the majority of forks progressed symmetrically. This
suggests that the increased fork speed is not the result of an
altered replication pausing behavior, but forks indeed progress
at a faster rate because of increased cyclin A/CDK2 activity.
The reason for increased replication fork velocity could relate
to elevated dNTP or histone levels, both of which are controlled
by the cell cycle machinery (De Cola et al., 2012; Karnani and
Dutta, 2011) and have been shown to limit the speed of fork
progression (Poli et al., 2012).
Despite clear signs of an active DNA damage response in
Cks2/ cells, we could not detect an expected delay in cell
cycle progression. Similarly, exogenous DNA damage at levels
sufficient to induce measureable DNA damage response and
cell cycle arrest in wild-type cells, failed to delay cell cycle
progression in Cks2/ cells. This demonstrates that CKS2 is
required as part of the cell cycle machinery to impose check-
point-dependent cell cycle delays. This could be due to the
role of CKS2 in stabilizing p27, which has been implicated in
the control of G2 (Nakayama et al., 2004).
p27 binds to both cyclin E/CDK2 and cyclin A/CDK2. We
found that only cyclin A/CDK2, but not cyclin E/CDK2, activity
was affected in Cks2/ cells (Figure S1B). A recent survey of
CDK-associated proteins indicated that CKS proteins interacted
mainly with cyclin A-associated CDK complexes but less so with
cyclin E complexes (Pagliuca et al., 2011). This could indicate
that CKS proteins impact more strongly on cyclin A/CDK2
complexes by controlling their associated p27 levels. During S
phase, cyclin E and cyclin A act sequentially to control events
in DNA replication. It is therefore possible that, by counteracting
SCFSKP2-dependent p27 degradation during mid/late S phase
when cyclin A expression is highest, CKS2 attenuates cyclin
A/CDK2 activity to adjust the dynamics and progression of
DNA replication.
CKS Proteins Determine Cortical Progenitor Cell Fate
To investigate the functional consequences of deregulated p27
levels, we examined the developing brain, as p27 is required
for neuronal maturation and migration through the developing
cortex in a dose-dependent manner. Cortex formation takes
place during embryonic days E11 to E17, when the balance
between cortical progenitor self-renewal and cell cycle exit/
differentiation determines neuronal fate and laminar formation.
Several studies have documented that the timing of cell cycle
transition is crucial for neuronal fate determination (Arai et al.,
2011; Lange et al., 2009; Calegari and Huttner, 2003; Pilaz
et al., 2009).
In Cks2/ brains, neuronal differentiation after the first asym-
metric cell division was inefficient and, consequently, lamination
of the neocortex was affected with fewer mature neurons in the(E) DNA damage inCks2/MEFs is due to increased cyclin A/CDK2 activity.Cks2
Whole-cell extracts were prepared and analyzed by western blotting as indicate
(F) Increased replication fork speed in Cks2/MEFs due to increased cyclin A/C
siRNA or siRNA against cyclin A. Fork speed was decreased after cyclin A deple
See also Figure S1.
Developmental Cell 23, 356–370, Aupper layers. Based on the differential expression pattern of
CKS1 and CKS2, we propose that the balance between CKS1
and CKS2 govern p27 levels in the developing neuronal layers
to control the timing of neuronal differentiation.
CKS2 in Higher Eukaryotes
Multiple levels of control exist in higher eukaryotes to tightly
govern SCFSKP2 activity during different phases of the cell cycle.
The CKS1/CKS2 axis adds an additional dimension to this
control. It remains to be investigated if other potential S phase-
specific SCFSKP2 substrates are also under the influence of
CKS1/CKS2 balance. The replicative and DNA damage re-
sponse defects observed in Cks2/ cells may suggest a role
for CKS2 as a tumor suppressor. Overexpression of CKS2 has
been associated with oncogenic roles (Liberal et al., 2012) but
this is not mutually exclusive of a potential role as a tumor
suppressor. Some genes, including p27, have been shown to
act as both oncogenes and tumor suppressors depending on
the cellular context (Sicinski et al., 2007). Further investigation
that combines the Cks2/ mutation with known tumor models
would shed insight into this important unexplored area.
EXPERIMENTAL PROCEDURES
Generation of Cks1–/– and Cks2–/– Murine Models
ES cells containing one disrupted allele by gene trapping for Cks1 and
Cks2 were obtained from International Gene Trap Consortiums (Nord et al.,
2006) (Cks1/ mice were constructed from clone S81H1 (Fred Hutchinson
Cancer Research Center) and Cks2/ mice were constructed using clone
DO27C12 (German Gene Trap Consortium). In both cases, the insertion was
mapped to the first intron. Mice were generated by standard techniques by
the Clinical Science Centre ES/Transgenic facility and maintained in a mixed
129/B6 background. All animal work is in compliance with UK Home Office
regulations and institutional review. Western blot using specific antibodies
confirmed that no mature proteins at the respective loci were produced in
the homozygous knockout mice, respectively.
Molecular Combing
MEF cells were pulse-labeled for 20 min with 50 mM IdU, quickly washed with
PBS and pulse-labeled for another 20 min with 100 mM CldU (Sigma-Aldrich).
Cells were then trypsinized, washed, and embedded in low melting agarose
plugs (5 3 105 cells/100 ml). After treatment with Proteinase K and Sarkosyl
(Sigma-Aldrich), and agarose digestion with b-agarase (New England Biolabs),
genomic DNA fibers were combed on silanised coverslips (Microsurfaces, Inc.)
and denatured with NaOH. Replicons were visualized using primary antibodies
specific for IdU and anti-CldU (Becton Dickenson and Axyll respectively) fol-
lowed by incubation with AlexaFluor-488 (green) and AlexaFluor-594 (red)-
conjugated secondary antibodies (Molecular Probes). Images of replicons
were captured using the Epifluorescence Microscope Pathway (Becton Dick-
inson) with Attovision software. Signals weremeasured using ImageJ (National
Cancer Institute, National Institutes of Health) with custom-made modifica-
tions. Replication fork velocities and interorigin distances were calculated
using formulas as depicted in Figure 2. Analysis of fork symmetry was per-
formed by measuring the right and left sides of 500 replicons. When the ratio
between the two sides was greater than ±0.3, the replicon was labeled as
‘‘asymmetrical.’’/MEFswere infectedwith retroviruses expressing control or cyclin A siRNAs.
d.
DK2 activity. Histogram of fork velocity in Cks2/MEFs, infected with control
tion, p < 0.001 (Mann-Whitney).
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Figure 5. Increased p27 Degradation in Cks2–/– MEFs Due to Unopposed CKS1 Action
(A) (Ai) Cell extracts from wild-type, Cks2/ and Cks1/ MEFs were analyzed by western blotting. CDK complexes were pulled down using a CKS1 affinity
column. Bound p27 was quantified and normalized to the levels of recovered CDK2. (Aii) As in (Ai), except that p27 was immunoprecipitated using an anti-p27
antibody. CDK2 associated with p27 was quantified and normalized to the p27 signal. (Aiii) Silencing Cks2 in wild-type MEFs decreases p27 levels. Wild-type
MEFs (WT) were infected with control siRNA or siRNA against Cks2. Western blotting demonstrating total CKS1 and CKS2 levels using an antibody that
recognizes both CKS1 and CKS2 (denoted CKS), p27 levels, and actin.
(B) Half-life of p27 in wild-type, Cks2/ and Cks1/MEFs synchronized with nocodazole release was determined after addition of cyclohexamide and western
blotting against p27. Tubulin served as a loading control.
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CKS2 in Replication and NeurodevelopmentImmunoprecipitation and Western Blotting
Cell extracts were prepared in RIPA buffer and sonicated. Soluble fraction was
collected after centrifugation. Protein content was determined by colorimetric
assay (Biorad). For immunoprecipitation, 1 mg of whole-cell extract was
applied to 30 ml of protein A Sepharose slurry (GE Healthcare) together with
5 mg of the specified antibodies. After overnight incubation at 4C and strin-
gency washes, elution was carried out by boiling in Laemmli buffer. Western
blotting was carried out using specific antibodies described in the Supple-
mental Experimental Procedures.
siRNA and shRNA
siRNA Smart pools were purchased from Dharmacon and transfected using
Hyperfect (QIAGEN) following the manufacturer’s instructions. Cells were
analyzed 48 hr after transfection.
For the shRNA vector against p53, viral particles were generated by stan-
dard transfections with helper plasmids in 293T cells. MEFs were exposed
to two rounds of infection of 3 hr and a last one overnight. Selection was
carried out after 24 hr with 1 mg/ml puromycin (InVivoGen).
Cell Cycle Analysis
Cells were harvested by trypsinization, washed in PBS, and fixed in ice-cold
70% ethanol overnight. Cells were then washed twice in PBS, treated with
RNaseA, and stained with propidium iodide (PI) for 2 hr at room temperature
before being run on a fluorescence-activated cell sorting (FACS) Calibur flow
cytometer (Becton Dickinson). For BrdU staining, cells were grown in the pres-
ence of BrdU (Sigma-Aldrich) at a final concentration of 1 mM for the durations
specified. Harvested cells were treated with 0.1 M borate buffer for 1 hr and
then with 3 ml of 2N HCl before labeling with anti-BrdU antibodies (Thermo
Fisher: Clone BU-1). Data were analyzed using the CellQuest software (Becton
Dickinson).
Drug Sensitivity Assay
Cells were seeded at a density of 104 per well on a 24-well plate. Six hours
later, aphidicolin (Sigma-Aldrich) was added at the concentrations indicated.
After 4 days, cells were fixed in 0.5% glutaraldehyde (Sigma-Aldrich) in PBS
and stained with Crystal Violet for 20 min, rinsed extensively with running
water, and then imaged. Quantification was performed by dissolving the incor-
porated Crystal Violet in 1% acetic acid and 0.5% SDS and measuring the
absorbance at 540 nm. Each point was performed as three experimental
replicates.
Determination of Protein Half-Life
Cells were seeded at 60% confluency (7 3 105 cells) in 100-mm plates,
synchronized released from nocodazole, and treatedwith 100 mg/ml cyclohex-
imide for the indicated times. Cells prepared for western blotting.
p27 Peptide Binding Assay
Recombinant CKS1-flag, or CKS2 or CKS2 mutant proteins were expressed
from Escherichia coli and purified by nickel-agarose chromatography in accor-
dance with the manufacturer’s instructions (QIAGEN). Biotin-labeled phos-
phorylated-p27 peptide was synthesized (biotin-Aca-SDG-SPN-AGS-VEQ-T
[p]PK-KPG-LRR-RQT-CONH2, Aca = aminocaproic acid) and coupled to a
streptavidin affinity column. Recombinant SKP1/SKP2 (Novus Biologicals)
were used at a ratio of 7 to 0.4 mM. CKS1-Flag-fusion protein with increasing(C) In vitro phospho-p27 binding assay. Top: Schematic experimental design. Sy
column. Recombinant CKS1-Flag fusion protein was incubated with the affinity co
row) or mutant CKS2 (that cannot bind phosphorylated p27 (Cks2-Mut)) in a 1:0.5
SKP2 complexes. After stringency washes and elution, western blotting against t
capable of competing with CKS1 for binding to phosphorylated p27 peptides.
(D) CKS1-dependent cellular p27 ubiquitylation is increased in Cks2/ MEFs. p
against ubiquitin to assess the level of p27 ubiquitylation in wild-type (WT), Cks1
(siCtrl) or siRNA against Cks1.
(E) siRNA-mediated silencing of Cks1 in Cks2/ MEFs restores wild-type p27 a
blotting recognizes both CKS1 and CKS2. Cyclin A-associated kinase activity w
See also Figure S2.
Developmental Cell 23, 356–370, Auconcentrations of CKS2 ormutantCKS2were incubated together with SKP1/2
complex in a 10-ml reaction volume containing 40 mmTris-HCl (pH 7.6),
2 mg/ml bovine serum albumin, 5 mm MgCl2, and 1 mm DTT. Incubation
was carried out at 4C for 2 hr, and then the beads were washed four times
with 1 ml portions of RIPA buffer. Following elution, samples were subjected
to SDS-PAGE and western blotting.
p27 Cellular Ubiquitylation Assay
Cellular ubiquitylation of p27 was determined as described previously (Mon-
tagnoli et al., 1999). Briefly, cells were treated with 10 mM MG132 (Sigma-
Aldrich) and denatured in 1% SDS and then diluted in RIPA lysis buffer
(50 mM Tris-HCI [pH 7.4], 0.25 M NaCl, 1% Triton X-100, 0.1% SDS, 1 mM
EDTA) in the presence of protease inhibitors, phosphatase inhibitors, and
10 mM N-ethylmaleimide (Sigma-Aldrich). A mixture of anti-p27 antibody
(3 ug) (BD Biosciences) and anti-phospho-(T187) p27 antibody (3 ug)
(Invitrogen) were used for immunoprecipitation. Beads were eluted with 8 M
urea and subjected to western blotting.
In Vitro Kinase Assay
Immunoprecipitates with cyclin A2, cyclin E, or CDK2 prepared from cell
lysates were incubated with 5 mg of histone H1 (New England Biolabs) and
[g-32P]ATP (PerkinElmer) for 10 min at 30C. Reaction mixture was resolved
by SDS-PAGE, and then phosphorylated histone H1 was analyzed by SDS-
PAGE and autoradiography.
Immunofluorescence and Preparation of Brain Sections
Embryonic day E13.5 brains were dissected and fixed by immersion in 4%
paraformaldehyde (PFA) solution overnight. Brains were cryoprotected in
30% sucrose solution, embedded in OCT medium (Thermo Fisher) and frozen
in isopentane (Sigma-Aldrich) on dry ice. Coronal cryosections (17 mm) were
made, mounted on a glass slide, and stored at 20C.
Sections were rehydrated in Tris-buffered saline (TBS) for 30 min and incu-
bated in 1% Triton in PBS and 10% normal goat serum (NGS) for 45 min.
Primary antibodies were incubated overnight at 4C in 0.2% Triton and 10%
NGS, followed by appropriate secondary antibody and staining with DAPI prior
to mounting.
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Figure 6. Neuronal Maturation Defects in Cks2–/– and Cks1–/– Mice
(A) Schematic representation of neuronal maturation in the developing cortex. Neuronal stem cells reside in the ventricular zone (VZ) on the neuroepithelium that
lines the ventricles. As neurons mature, they sequentially express the markers Pax6, Tbr2, and then Tbr1 as they migrate outward toward the cortical plate (CP).
Right: Representative immunofluorescence staining of an E13.5 cortex in a wild-type mouse.
(B) Quantification of Pax6, Tbr2, and Tbr1 signals in E13.5 Cks2/ and Cks1/ brains compared to wild-type. The respective intensity of signals from specific
antibody staining was normalized against the signal of DAPI in each sample. Each data point is an average of three experimental replicates (three fetal brains of
equivalent coronal sections). Error bars represent standard deviation. Representative images from each genotype are inserted next to the graphs.
See also Figure S3.
Developmental Cell
CKS2 in Replication and Neurodevelopment
368 Developmental Cell 23, 356–370, August 14, 2012 ª2012 Elsevier Inc.Open access under CC BY license.
p27 Cks2 
Cks1 ub 
ub 
ub 
Skp2 
Cyclin A/Cdk2 
p27 
Cyclin A/Cdk2 p27 
P 
p27 
P 
p27 
P 
Figure 7. Model Depicting How CKS2 Antagonizes CKS1 in the
Control of p27
CKS1 mediates recognition of phopshorylated p27 by the SCFSKP2 and
promotes its ubiquitylation and destruction. CKS2 shares the anion pocket
that recognizes p27 with CKS1 but not the N-terminal residues that recruit
SKP2. CKS2 competes with CKS1 for binding to p27 and protects p27 from
degradation.
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